{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:49:00Z","timestamp":1789429740644,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11916-025-01358-3","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:03:39Z","timestamp":1737705819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nutraceuticals and Headache 2024: Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9879-6638","authenticated-orcid":false,"given":"Stewart J.","family":"Tepper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4633-3997","authenticated-orcid":false,"given":"Katharine","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"1358_CR1","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3182535d0c","volume":"78","author":"S Holland","year":"2012","unstructured":"Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1346\u201353. https:\/\/doi.org\/10.1212\/WNL.0b013e3182535d0c.","journal-title":"Neurology"},{"issue":"2 Suppl 2","key":"1358_CR2","first-page":"S1","volume":"39","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Davenport W, Mackie G, Worthington I, Aub\u00e9 M, Christie SN, Gladstone J, Becker WJ. Canadian Headache Society Prophylactic Guidelines Development Group. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):S1\u201359.","journal-title":"Can J Neurol Sci"},{"key":"1358_CR3","doi-asserted-by":"crossref","unstructured":"Medrea I, Cooper P, Langman M, Sandoe CH, Amoozegar F, Hussain WM, Bradi AC, Dawe J, Guay M, Perreault F, Reid S, Todd C, Skidmore B, Christie SJ. Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review, and Meta-analysis. Can J Neurol Sci. 2024, in press.","DOI":"10.1017\/cjn.2024.285"},{"key":"1358_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0022-510x(95)00196-1","volume":"134","author":"KMA Welch","year":"1995","unstructured":"Welch KMA, Ramadan NM. Mitochondria, magnesium and migraine. J Neurol Sci. 1995;134:9\u201314. https:\/\/doi.org\/10.1016\/0022-510x(95)00196-1.","journal-title":"J Neurol Sci"},{"key":"1358_CR5","doi-asserted-by":"publisher","unstructured":"Ashoori M, Saedisomeolia A, Riboflavin. (Vitamin B2) and oxidative stress: a review. Br J Nutr. 2014;111:1985\u201391. https:\/\/doi.org\/10.1017\/S0007114514000178.","DOI":"10.1017\/S0007114514000178"},{"key":"1358_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12950-016-0145-0","volume":"13","author":"S Dey","year":"2016","unstructured":"Dey S, Bishayi B. Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation. J Inflamm (Lond). 2016;13:36. https:\/\/doi.org\/10.1186\/s12950-016-0145-0.","journal-title":"J Inflamm (Lond)"},{"key":"1358_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fneur.2017.00333","volume":"8","author":"ET Marashly","year":"2017","unstructured":"Marashly ET, Bohlega SA. Riboflavin has neuroprotective potential: focus on Parkinson\u2019s Disease and Migraine. Front Neurol. 2017;8:333. https:\/\/doi.org\/10.3389\/fneur.2017.00333.","journal-title":"Front Neurol"},{"key":"1358_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1046\/j.1526-4610.2000.00005.x","volume":"40","author":"PS S\u00e1ndor","year":"2000","unstructured":"S\u00e1ndor PS, Afra J, Ambrosini A, Schoenen J. Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache. 2000;40:30\u20135. https:\/\/doi.org\/10.1046\/j.1526-4610.2000.00005.x.","journal-title":"Headache"},{"key":"1358_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1526-4610.2000.00005.x","volume":"63","author":"J Zempleni","year":"1996","unstructured":"Zempleni J, Galloway JR, McCormick DB. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr. 1996;63:54\u201366. https:\/\/doi.org\/10.1046\/j.1526-4610.2000.00005.x.","journal-title":"Am J Clin Nutr"},{"key":"1358_CR10","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1080\/1028415X.2022.2126760","volume":"26","author":"H Li","year":"2023","unstructured":"Li H, Krall JR, Frankenfeld C, Slavin M. Nutritional intake of riboflavin (vitamin B2) and migraine: a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) 2001\u20132004. Nutr Neurosci. 2023;26:1068\u201377. https:\/\/doi.org\/10.1080\/1028415X.2022.2126760.","journal-title":"Nutr Neurosci"},{"key":"1358_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1212\/wnl.50.2.466","volume":"50","author":"J Schoenen","year":"1998","unstructured":"Schoenen J, Jacquy J, Lanaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50:466\u201370. https:\/\/doi.org\/10.1212\/wnl.50.2.466.","journal-title":"Neurology"},{"key":"1358_CR12","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1080\/1028415X.2021.1904542","volume":"25","author":"YS Chen","year":"2022","unstructured":"Chen YS, Lee HF, Tsai CH, Hsu YY, Fang CJ, Chen CJ, Hung YH, Hu FW. Effect of vitamin B2 supplementation on migraine prophylaxis: a systematic review and meta-analysis. Nutr Neurosci. 2022;25:1801\u201312. https:\/\/doi.org\/10.1080\/1028415X.2021.1904542.","journal-title":"Nutr Neurosci"},{"key":"1358_CR13","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1- 211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"1358_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.braindev.2020.04.002","volume":"42","author":"G Yamanaka","year":"2020","unstructured":"Yamanaka G, Suzuki S, Takeshita M, Go S, Morishita N, Takamatsu T, Daida A, Morichi S, Ishida Y, Oana S, Nara S, Shimura M, Nishimata S, Kawashima H. Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine. Brain Dev. 2020;42:523\u20138. https:\/\/doi.org\/10.1016\/j.braindev.2020.04.002.","journal-title":"Brain Dev"},{"key":"1358_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pediatrneurol.2020.09.009","volume":"114","author":"R Das","year":"2021","unstructured":"Das R, Qubty W. Retrospective observational study on Riboflavin Prophylaxis in Child and adolescent migraine. Pediatr Neurol. 2021;114:5\u20138. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2020.09.009.","journal-title":"Pediatr Neurol"},{"key":"1358_CR16","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1177\/0883073808318053","volume":"23","author":"SC MacLennan","year":"2008","unstructured":"MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol. 2008;23:1300\u20134. https:\/\/doi.org\/10.1177\/0883073808318053.","journal-title":"J Child Neurol"},{"key":"1358_CR17","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1177\/0333102410365106","volume":"30","author":"J Bruijn","year":"2010","unstructured":"Bruijn J, Duivenvoorden H, Passchier J, Locher H, Dijkstra N, Arts WF. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial. Cephalalgia. 2010;30:1426\u201334. https:\/\/doi.org\/10.1177\/0333102410365106.","journal-title":"Cephalalgia"},{"key":"1358_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1468-2982.2002.00335.x","volume":"22","author":"TD Rozen","year":"2002","unstructured":"Rozen TD, Oshinsky ML, Gebeline CA, Bradley KC, Young WB, Shechter AL, Silberstein SD. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002;22:137\u201341. https:\/\/doi.org\/10.1046\/j.1468-2982.2002.00335.x.","journal-title":"Cephalalgia"},{"key":"1358_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1177\/0333102411406755","volume":"31","author":"SK Slater","year":"2011","unstructured":"Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, Manning P, Powers SW, Hershey A. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia. 2011;31:897\u2013905. https:\/\/doi.org\/10.1177\/0333102411406755.","journal-title":"Cephalalgia"},{"key":"1358_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13760-016-0697-z","volume":"117","author":"A Shoeibi","year":"2017","unstructured":"Shoeibi A, Olfati N, Soltani Sabi M, Salehi M, Mali S, Akbari Oryani M. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial. Acta Neurol Belg. 2017;117:103\u20139. https:\/\/doi.org\/10.1007\/s13760-016-0697-z.","journal-title":"Acta Neurol Belg"},{"key":"1358_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eujim.2017.10.003","volume":"16","author":"M Dahri","year":"2017","unstructured":"Dahri M, Hashemilar M, Asghari-Jafarabadi M, Tarighat\u2010Esfanjani A. Efficacy of coenzyme Q10 for the prevention of migraine in women: a randomized, double\u2010blind, placebo\u2010controlled study. Eur J Integr Med. 2017;16:8\u201314. https:\/\/doi.org\/10.1016\/j.eujim.2017.10.003.","journal-title":"Eur J Integr Med"},{"key":"1358_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/1028415X.2017.1421039","volume":"22","author":"M Dahri","year":"2019","unstructured":"Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: effects on clinical features and inflammatory markers. Nutr Neurosci. 2019;22:607\u201315. https:\/\/doi.org\/10.1080\/1028415X.2017.1421039.","journal-title":"Nutr Neurosci"},{"key":"1358_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/ane.13051","volume":"139","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Li Y, Lu S, Huang W, Di W. Efficacy of CoQ10 as supplementation for migraine: a meta-analysis. Acta Neurol Scand. 2019;139:284\u201393. https:\/\/doi.org\/10.1111\/ane.13051.","journal-title":"Acta Neurol Scand"},{"key":"1358_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1212\/01.WNL.0000151975.03598.ED","volume":"64","author":"PS Sandor","year":"2005","unstructured":"Sandor PS, DiClemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J. A randomized controlled trial of coenzyme Q10 in migraine prophylaxis. Neurology. 2005;64:713\u20135. https:\/\/doi.org\/10.1212\/01.WNL.0000151975.03598.ED.","journal-title":"Neurology"},{"key":"1358_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/1028415X.2019.1572940","volume":"23","author":"M Parohan","year":"2020","unstructured":"Parohan M, Sarraf P, Javanbakht MH, Ranji-Burachaloo S, Djalali M. Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Neurosci. 2020;23:868\u201375. https:\/\/doi.org\/10.1080\/1028415X.2019.1572940.","journal-title":"Nutr Neurosci"},{"key":"1358_CR26","doi-asserted-by":"publisher","unstructured":"Gaul C, Diener HC, Danesch U, Migravent Study Group. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015;16. https:\/\/doi.org\/10.1186\/s10194-015-0516-6.","DOI":"10.1186\/s10194-015-0516-6"},{"key":"1358_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.eujim.2018.06.009","volume":"21","author":"E Nattagh-Eshtivani","year":"2018","unstructured":"Nattagh-Eshtivani E, Dahri M, Hashemilar M, Tarighat-Esfanjani A. The effect of coenzyme Q10 supplementation on serum levels of lactate, pyruvate, matrix metalloproteinase 9 and nitric oxide in women with migraine. A double blind, placebo, controlled randomized clinical trial. Eur J Integr Med. 2018;21:70\u20136. https:\/\/doi.org\/10.1016\/j.eujim.2018.06.009.","journal-title":"Eur J Integr Med"},{"key":"1358_CR28","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/0333102418821661","volume":"39","author":"P Hajihashemi","year":"2019","unstructured":"Hajihashemi P, Askari G, Khorvash F, Reza Maracy M, Nourian M. The effects of concurrent coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial. Cephalalgia. 2019;39:648\u201354. https:\/\/doi.org\/10.1177\/0333102418821661.","journal-title":"Cephalalgia"},{"key":"1358_CR29","doi-asserted-by":"publisher","first-page":"e039358","DOI":"10.1136\/bmjopen-2020-039358","volume":"11","author":"S Sazali","year":"2021","unstructured":"Sazali S, Badrin S, Norhayati MN, Idris NS. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis. BMJ Open. 2021;11:e039358. https:\/\/doi.org\/10.1136\/bmjopen-2020-039358.","journal-title":"BMJ Open"},{"key":"1358_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/abr.abr_235_20","volume":"11","author":"O Yaghini","year":"2022","unstructured":"Yaghini O, Hoseini N, Ghazavi MR, Mansouri V, Nasiri J, Moosavian T, Salehi MM. A comparative study on the efficacy of Coenzyme Q10 and Amitriptyline in the prophylactic treatment of migraine headaches in children: a randomized controlled trial. Adv Biomed Res. 2022;11:43. https:\/\/doi.org\/10.4103\/abr.abr_235_20.","journal-title":"Adv Biomed Res"},{"key":"1358_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1526-4610.2007.00652.x","volume":"47","author":"AD Hershey","year":"2007","unstructured":"Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, Segers A, Burdine D, Manning P, Kabbouche MA. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007;47:73\u201380. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00652.x.","journal-title":"Headache"},{"key":"1358_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1212\/wnl.35.3.372","volume":"35","author":"S Ogashara","year":"1985","unstructured":"Ogashara S, Yorifuji S, Nishikawa Y, Takahashi M, Wada K, Hazama T, Nakamura Y, Hashimoto S, Kono N, Tarui S. Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayres syndrome. Neurology. 1985;35:372\u20137. https:\/\/doi.org\/10.1212\/wnl.35.3.372.","journal-title":"Neurology"},{"key":"1358_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jpba.2017.11.029","volume":"149","author":"K V\u00e9gh","year":"2018","unstructured":"V\u00e9gh K, Riethm\u00fcller E, Hossz\u00fa L, Darcsi A, M\u00fcller J, Alberti \u00c1, T\u00f3th A, B\u00e9ni S, K\u00f6ncz\u00f6l \u00c1, Balogh GT, K\u00e9ry \u00c1. Three newly identified lipophilic flavonoids in Tanacetum parthenium supercritical fluid extract penetrating the blood-brain barrier. J Pharm Biomed Anal. 2018;149:488\u201393. https:\/\/doi.org\/10.1016\/j.jpba.2017.11.029.","journal-title":"J Pharm Biomed Anal"},{"key":"1358_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/molecules26010022","volume":"26","author":"L Recinella","year":"2021","unstructured":"Recinella L, Chiavaroli A, di Giacomo V, Antolini MD, Acquaviva A, Leone S, Brunetti L, Menghini L, Ak G, Zengin G, Di Simone SC, Ferrante C, Orlando G. Anti-inflammatory and neuromodulatory effects induced by Tanacetum parthenium water extract: results from in silico, in vitro and ex vivo studies. Molecules. 2021;26:22. https:\/\/doi.org\/10.3390\/molecules26010022.","journal-title":"Molecules"},{"key":"1358_CR35","doi-asserted-by":"publisher","first-page":"110783","DOI":"10.1016\/j.fct.2019.110783","volume":"133","author":"V di Giacomo","year":"2019","unstructured":"di Giacomo V, Ferrante C, Ronci M, Cataldi A, Di Valerio V, Rapino M, Recinella L, Chiavaroli A, Leone S, Vladimir-Kne\u017eevi\u0107 S, Kindl M, Brunetti L, Menghini L, Orlando G. Multiple pharmacological and toxicological investigations on Tanacetum parthenium and Salix alba extracts: focus on potential application as anti-migraine agents. Food Chem Toxicol. 2019;133:110783. https:\/\/doi.org\/10.1016\/j.fct.2019.110783.","journal-title":"Food Chem Toxicol"},{"key":"1358_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/19390210902861809","volume":"6","author":"E Saranitzky","year":"2009","unstructured":"Saranitzky E, White CM, Baker EL, Baker WL, Coleman CI. Feverfew for migraine prophylaxis: a systematic review. J Diet Suppl. 2009;6:91\u2013103. https:\/\/doi.org\/10.1080\/19390210902861809.","journal-title":"J Diet Suppl"},{"key":"1358_CR37","doi-asserted-by":"publisher","first-page":"CD002286","DOI":"10.1002\/14651858.CD002286.pub3","volume":"4","author":"B Wider","year":"2015","unstructured":"Wider B, Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2015;4:CD002286. https:\/\/doi.org\/10.1002\/14651858.CD002286.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1358_CR38","doi-asserted-by":"publisher","unstructured":"Diener_HC PGV, Henneicke-von-Zepelin SJFM. Effiicacy and safety of 6.25\u00a0mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention\u2013a randomized, double blind, multicentre, placebo-controlled study. Cephalalgia. 2005;25:1031\u201341. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.00950.x.","DOI":"10.1111\/j.1468-2982.2005.00950.x"},{"key":"1358_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/acupmed-2012-010195","volume":"30","author":"EC Ferro","year":"2012","unstructured":"Ferro EC, Biagini AP, da Silva \u00cdE, Silva ML, Silva JR. The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study. Acupunct Med. 2012;30:252\u20137. https:\/\/doi.org\/10.1136\/acupmed-2012-010195.","journal-title":"Acupunct Med"},{"key":"1358_CR40","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/ptr.6701","volume":"34","author":"AL Lopresti","year":"2020","unstructured":"Lopresti AL, Smith SJ, Drummond PD. Herbal treatments for migraine: a systematic review of randomised-controlled studies. Phytother Res. 2020;34:2493\u2013517. https:\/\/doi.org\/10.1002\/ptr.6701.","journal-title":"Phytother Res"},{"key":"1358_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12906-017-1933-7","volume":"17","author":"A Guilbot","year":"2017","unstructured":"Guilbot A, Bangratz M, Ait Abdellah S, Lucas C. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study. BMC Complement Altern Med. 2017;17:433. https:\/\/doi.org\/10.1186\/s12906-017-1933-7.","journal-title":"BMC Complement Altern Med"},{"key":"1358_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13052-019-0624-z","volume":"45","author":"F Moscano","year":"2019","unstructured":"Moscano F, Guiducci M, Maltoni L, Striano P, Ledda MG, Zoroddu F, Raucci U, Villa MP, Parisi P. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache. Ital J Pediatr. 2019;45:36. https:\/\/doi.org\/10.1186\/s13052-019-0624-z.","journal-title":"Ital J Pediatr"},{"issue":"6495","key":"1358_CR43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bmj.291.6495.569","volume":"291","author":"ES Johnson","year":"1985","unstructured":"Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed). 1985;291(6495):569\u201373. https:\/\/doi.org\/10.1136\/bmj.291.6495.569.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1358_CR44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/nu14051089","volume":"14","author":"I Domitrz","year":"2022","unstructured":"Domitrz I, Cegielska J. Magnesium as an important factor in the Pathogenesis and treatment of migraine-from theory to practice. Nutrients. 2022;14:1089. https:\/\/doi.org\/10.3390\/nu14051089.","journal-title":"Nutrients"},{"issue":"5","key":"1358_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1475-097x.1994.tb00412.x","volume":"14","author":"U Myrdal","year":"1994","unstructured":"Myrdal U, Leppert J, Edvinsson L, Ekman R, Hedner T, Nilsson H, Ringqvist I. Magnesium sulphate infusion decreases circulating calcitonin gene-related peptide (CGRP) in women with primary Raynaud\u2019s phenomenon. Clin Physiol. 1994;14(5):539\u201346. https:\/\/doi.org\/10.1111\/j.1475-097x.1994.tb00412.x.","journal-title":"Clin Physiol"},{"key":"1358_CR46","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.4103\/0028-3886.359247","volume":"70","author":"R Mahajan","year":"2022","unstructured":"Mahajan R, Anand KS, Mahajan RK, Garg J, Juneja A. Serum magnesium levels during the Ictal and Interictal Phase in patients of migraine: a prospective observational study. Neurol India. 2022;70:1852\u20135. https:\/\/doi.org\/10.4103\/0028-3886.359247.","journal-title":"Neurol India"},{"key":"1358_CR47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/head.14065","volume":"61","author":"M Slavin","year":"2021","unstructured":"Slavin M, Li H, Khatri M, Frankenfeld C. Dietary magnesium and migraine in adults: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2001\u20132004. Headache. 2021;61:276\u201386. https:\/\/doi.org\/10.1111\/head.14065.","journal-title":"Headache"},{"key":"1358_CR48","doi-asserted-by":"publisher","first-page":"653765","DOI":"10.3389\/fnut.2021.653765","volume":"8","author":"SH Meng","year":"2021","unstructured":"Meng SH, Wang MX, Kang LX, Fu JM, Zhou HB, Li X, Li X, Li XT, Zhao YS. Dietary intake of calcium and magnesium in relation to severe headache or migraine. Front Nutr. 2021;8:653765. https:\/\/doi.org\/10.3389\/fnut.2021.653765.","journal-title":"Front Nutr"},{"key":"1358_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/head.13217","volume":"58","author":"A von Luckner","year":"2018","unstructured":"von Luckner A, Riederer F. Magnesium in Migraine Prophylaxis-Is there an evidence-based rationale? A systematic review. Headache. 2018;58:199\u2013209. https:\/\/doi.org\/10.1111\/head.13217.","journal-title":"Headache"},{"key":"1358_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00394-019-01905-w","volume":"59","author":"N Veronese","year":"2020","unstructured":"Veronese N, Demurtas J, Pesolillo G, Celotto S, Barnini T, Calusi G, Caruso MG, Notarnicola M, Reddavide R, Stubbs B, Solmi M, Maggi S, Vaona A, Firth J, Smith L, Koyanagi A, Dominguez L, Barbagallo M. Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur J Nutr. 2020;59:263\u201372. https:\/\/doi.org\/10.1007\/s00394-019-01905-w.","journal-title":"Eur J Nutr"},{"key":"1358_CR51","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/nu13051397","volume":"13","author":"V Morel","year":"2021","unstructured":"Morel V, Pickering ME, Goubayon J, Djobo M, Macian N, Pickering G. Magnesium for Pain Treatment in 2021? State of the art. Nutrients. 2021;13:1397. https:\/\/doi.org\/10.3390\/nu13051397.","journal-title":"Nutrients"},{"issue":"Pt 7","key":"1358_CR52","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/brain\/aww097","volume":"139","author":"LH Schulte","year":"2016","unstructured":"Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt 7):1987\u201393. https:\/\/doi.org\/10.1093\/brain\/aww097.","journal-title":"Brain"},{"key":"1358_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/brain\/aww097","volume":"87","author":"LH Schulte","year":"2020","unstructured":"Schulte LH, Mehnert J, May A. Longitudinal neuroimaging over 30 days: temporal characteristics of migraine. Ann Neurol. 2020;87:646\u201351. https:\/\/doi.org\/10.1093\/brain\/aww097.","journal-title":"Ann Neurol"},{"key":"1358_CR54","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/head.14736","volume":"64","author":"A May","year":"2024","unstructured":"May A. Beyond aura: understanding migraine as a cycling pan-sensory threshold disease. Headache. 2024;64:715\u20137. https:\/\/doi.org\/10.1111\/head.14736.","journal-title":"Headache"},{"key":"1358_CR55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1468-2982.1995.015003224.x","volume":"15","author":"M Leone","year":"1995","unstructured":"Leone M, Lucini V, D\u2019Amico D, Moschiano F, Maltempo C, Fraschini F, Bussone G. Twenty four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia. 1995;15:224\u20139. https:\/\/doi.org\/10.1046\/j.1468-2982.1995.015003224.x.","journal-title":"Cephalalgia"},{"key":"1358_CR56","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1212\/WNL.0b013e3181f9618c","volume":"75","author":"KB Alstadhaug","year":"2010","unstructured":"Alstadhaug KB, Odeh F, Salvesen R, Bekkelund SI. Prophylaxis of migraine with melatonin: a randomized controlled trial. Neurology. 2010;75:1527\u201332. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f9618c.","journal-title":"Neurology"},{"key":"1358_CR57","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","volume":"87","author":"AL Goncalves","year":"2016","unstructured":"Goncalves AL, Martini Ferreira A, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MF. Randomised clinical trial comparing melatonin 3\u00a0mg, Amitriptyline 25\u00a0mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016;87:1127\u201332. https:\/\/doi.org\/10.1136\/jnnp-2016-313458.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1358_CR58","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/head.12862","volume":"56","author":"A Gelfand","year":"2016","unstructured":"Gelfand A, Goadsby PG. The role of melatonin in the treatment of primary Headache disorders. Headache. 2016;56:1257\u201366. https:\/\/doi.org\/10.1111\/head.12862.","journal-title":"Headache"},{"key":"1358_CR59","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1468-2982.1996.1607494.x","volume":"16","author":"M Leone","year":"1996","unstructured":"Leone M, D\u2019Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia. 1996;16:494\u20136. https:\/\/doi.org\/10.1046\/j.1468-2982.1996.1607494.x.","journal-title":"Cephalalgia"},{"key":"1358_CR60","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1046\/j.1526-4610.2002.02181.x","volume":"42","author":"T Pringsheim","year":"2002","unstructured":"Pringsheim T, Magnoux E, Dobson CF, Hamel E, Aub\u00e9 M. Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study. Headache. 2002;42:787\u201392. https:\/\/doi.org\/10.1046\/j.1526-4610.2002.02181.x.","journal-title":"Headache"},{"key":"1358_CR61","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1526-4610.2006.00386_5.x","volume":"46","author":"RC Spears","year":"2006","unstructured":"Spears RC. Hemicrania continua: a case in which a patient experienced complete relief on melatonin. Headache. 2006;46:524\u20137. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00386_5.x.","journal-title":"Headache"},{"key":"1358_CR62","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/head.12489","volume":"55","author":"TD Rozen","year":"2015","unstructured":"Rozen TD. How effective is melatonin as a preventive treatment for hemicrania continua? A clinic-based study. Headache. 2015;55:430\u20136. https:\/\/doi.org\/10.1111\/head.12489.","journal-title":"Headache"},{"key":"1358_CR63","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/head.12796","volume":"56","author":"N Tariq","year":"2016","unstructured":"Tariq N, Estemalik E, Vij B, Kriegler JS, Tepper SJ, Stillman MJ. Long-term outcomes and clinical characteristics of Hypnic Headache Syndrome: 40 patients Series from a Tertiary Referral Center. Headache. 2016;56:717\u201324. https:\/\/doi.org\/10.1111\/head.12796.","journal-title":"Headache"},{"key":"1358_CR64","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5664\/jcsm.6462","volume":"13","author":"LA Erland","year":"2017","unstructured":"Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13:275\u201381. https:\/\/doi.org\/10.5664\/jcsm.6462.","journal-title":"J Clin Sleep Med"},{"key":"1358_CR65","doi-asserted-by":"publisher","first-page":"115263","DOI":"10.1016\/j.jep.2022.115263","volume":"293","author":"\u0141 Kulinowski","year":"2022","unstructured":"Kulinowski \u0141, Luca SV, Minceva M, Skalicka-Wo\u017aniak K. A review on the ethnobotany, phytochemistry, pharmacology and toxicology of butterbur species (Petasites L). J Ethnopharmacol. 2022;293:115263. https:\/\/doi.org\/10.1016\/j.jep.2022.115263.","journal-title":"J Ethnopharmacol"},{"key":"1358_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/BTAT.S54023","volume":"4","author":"JM Prieto","year":"2014","unstructured":"Prieto JM. Update on the efficacy and safety of Petadolex, a butterbur extract for migraine prophylaxis. Botanics Targets Ther. 2014;4:1\u20139. https:\/\/doi.org\/10.2147\/BTAT.S54023.","journal-title":"Botanics Targets Ther"},{"key":"1358_CR67","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0022-3565(24)29533-1","volume":"297","author":"GJ Wang","year":"2001","unstructured":"Wang GJ, Shum AY, Lin YL, Liao JF, Wu XC, Ren J, Chen CF. Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasin, a hypotensive sesquiterpene from Petasites Formosanus. J Pharmacol Exp Ther. 2001;297:240\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"1358_CR68","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1111\/bph.13917","volume":"174","author":"S Benemei","year":"2017","unstructured":"Benemei S, De Logu F, Li Puma S, Marone IM, Coppi E, Ugolini F, Liedtke W, Pollastro F, Appendino G, Geppetti P, Materazzi S, Nassini R. The anti-migraine component of butterbur extracts, isopetasin, desensitizes peptidergic nociceptors by acting on TRPA1 cation channel. Br J Pharmacol. 2017;174:2897\u2013911. https:\/\/doi.org\/10.1111\/bph.13917.","journal-title":"Br J Pharmacol"},{"key":"1358_CR69","doi-asserted-by":"publisher","first-page":"864689","DOI":"10.3389\/fneur.2022.864689","volume":"13","author":"J Borlak","year":"2022","unstructured":"Borlak J, Diener HC, Kleeberg-Hartmann J, Messlinger K, Silberstein S. Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A narrative review. Front Neurol. 2022;13:864689. https:\/\/doi.org\/10.3389\/fneur.2022.864689.","journal-title":"Front Neurol"},{"key":"1358_CR70","first-page":"303","volume":"6","author":"W Grossman","year":"2001","unstructured":"Grossman W, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Altern Med Rev. 2001;6:303\u201310.","journal-title":"Altern Med Rev"},{"key":"1358_CR71","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1212\/01.wnl.0000147290.68260.11","volume":"63","author":"RB Lipton","year":"2004","unstructured":"Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment. Neurology. 2004;63:2240\u20134. https:\/\/doi.org\/10.1212\/01.wnl.0000147290.68260.11.","journal-title":"Neurology"},{"key":"1358_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000076535","volume":"51","author":"HC Diener","year":"2004","unstructured":"Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol. 2004;51:89\u201397. https:\/\/doi.org\/10.1159\/000076535.","journal-title":"Eur Neurol"},{"key":"1358_CR73","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejpain.2007.06.003","volume":"12","author":"R Oelkers-Ax","year":"2008","unstructured":"Oelkers-Ax R, Leins A, Parzer P, Hillecke T, Bolay HV, Fischer J, Bender S, Hermanns U, Resch F. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain. 2008;12:301\u201313. https:\/\/doi.org\/10.1016\/j.ejpain.2007.06.003.","journal-title":"Eur J Pain"},{"key":"1358_CR74","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1046\/j.1526-4610.2003.03015.x","volume":"43","author":"U Danesch","year":"2003","unstructured":"Danesch U, Rittinghausen R. Safety of a patented special butterbur root extract for migraine prevention. Headache. 2003;43:76\u20138. https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03015.x.","journal-title":"Headache"},{"key":"1358_CR75","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/toxsci\/kfp216","volume":"112","author":"N Anderson","year":"2009","unstructured":"Anderson N, Meier T, Borlak J. Toxicogenomics applied to cultures of human hepatocytes enabled an identification of novel petasites hybridus extracts for the treatment of migraine with improved hepatobiliary safety. Toxicol Sci. 2009;112:507\u201320. https:\/\/doi.org\/10.1093\/toxsci\/kfp216.","journal-title":"Toxicol Sci"},{"key":"1358_CR76","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/head.12789","volume":"56","author":"T Rajapakse","year":"2016","unstructured":"Rajapakse T, Pringsheim T. Nutraceuticals in migraine: a Summary of existing guidelines for Use. Headache. 2016;56:808\u201316. https:\/\/doi.org\/10.1111\/head.12789.","journal-title":"Headache"},{"key":"1358_CR77","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/jcm8050652","volume":"8","author":"N Anderson","year":"2019","unstructured":"Anderson N, Borlak J. Hepatobiliary events in migraine therapy with herbs: the case of petadolex, a petasites hybridus extract. J Clin Med. 2019;8:652. https:\/\/doi.org\/10.3390\/jcm8050652.","journal-title":"J Clin Med"},{"key":"1358_CR78","unstructured":"Din L, Lui F, Butterbur. 2023 Jun 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. PMID: 30725845."},{"key":"1358_CR79","unstructured":"Butterbur. In: National Center on Complementary and Integrative Health. 2020. https:\/\/www.nccih.nih.gov\/health\/butterbur. Accessed 1 Sep 2024."}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01358-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-025-01358-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01358-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:02:57Z","timestamp":1771275777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-025-01358-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1007\/s11916-025-01358-3","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"2 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Stewart Tepper has the following disclosures: Nutrceutical companies: none Advisory role: Aeon, Abbvie, Alphasights, Amgen, Aruene, Atheneum, Axsome Therapeutics, Becker Pharmaceutical Consulting, ClearView Healthcare Partners, ClickTherapeutics, CoolTech, CRG, Decision Resources, Defined Health, DRG, Eli Lilly, ExpertConnect, FCB Health, Fenix, GLG, Guidepoint Global, Health Advances, Health Science Communications, HMP Communications, Impel, Initiatior Pharma, InteractiveForums, Keyquest, Ki Health Partners, Krog and Partners, Lundbeck, M3 Global Research, Magnolia Innovation, MJH Holdings, Miravo Healthcare, Neurofront Therapeutics, Neurolief, Novartis, P Value Communications, Pain Insights, Inc, Palion Medical, Pfizer, Pulmatrix, Putnam Associates, Rehaler, SAI MedPartners, Satsuma, Slingshot Insights, Spherix Global Insights, Strategy Inc, Synapse Medical Communication, System Analytic, Taylor and Francis, Tegus, Teva, Theranica, Trinity Partners, Unity HA, Vial, XOC. Honoraria lecture fees, continuing medical education: American Academy of Neurology, American Headache Society, Annenberg Center for Health Sciences, Catamount Medical Education, Diamond Headache Clinic, Forefront Collaborative, Haymarket Medical Education, HMP Global, Medical Education Speakers Network, Medical Learning Institute Peerview, Miller Medical Education, National Association for Continuing Education, North American Center for CME, The Ohio State University, Physicians\u2019 Education Resource, PlatformQ Education, Primed, Vindico Medical Education, WebMD\/Medscape. Honoraria lecture fees, other: AbbVie, Eli Lilly, Pfizer, Teva. Research funding: Aeon, Abbvie, Eli Lilly, Lundbeck, Neurolief, Pfizer, Suven. Travel: AbbVie, American Headache Society, Diamond Headache Clinic, Eli Lilly, Pfizer. Stock, stock options, patents, royalties, manuscript fees, subsidies, endowments: none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Katharine Tepper has no financial or non-financial disclosures or competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}